Risk factor
Very poor trading liquidity
Profitability factor
Greatly undervalued vs peers
About
Rekah Pharmaceutical Industry Ltd., established in 1941 and headquartered in Holon, Israel, specializes in the production, marketing, distribution, and sale of a broad spectrum of healthcare items across Israel. The company's offerings include both prescription and over-the-counter medicines, dermo-cosmetic products, vitamins, and nutritional supplements. Its extensive portfolio comprises approximately 280 distinct pharmaceutical drugs used in various medical sectors. These encompass steroid tablets, antibiotics (such as penicillin and cephalosporin), eye drops and ointments for allergies, infections, and dryness, baby products, and dermatological treatments.
Company Valuation
Based on key historical and expected multiples, the stock is greatly undervalued relative to its peers. In particular, the stock is of fair value on EV/EBITDA, undervalue